Drug Database
Back to search

United States· US:61168-101_c67c4873-6322-42dc-8a2b-da3a7012a435

KYBELLA

A deoxycholic acid product containing deoxycholic acid, registered in United States by Kythera Biopharmaceuticals Inc.. The same ATC class is registered in 7 of our 19 countries.

ATC D11AX24US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedKYBELLAATCD11AX24REGISTER NO.US:61168-101_c67c4873…PACKS LISTED4CHECKEDSeptember 20, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about deoxycholic acidAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Deoxycholic acid is registered in 7 of 19 countries.

Countries holding a registration under ATC D11AX24 (deoxycholic acid), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 4 of them publish a price we can compare per daily dose
Search deoxycholic acid products by name

Deoxycholic acid · ATC D11AX24

7 / 19 countries

  • Belgiumprice
  • Canada
  • Finlandprice
  • Netherlands
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
DEOXYCHOLIC ACID
Manufacturer
Kythera Biopharmaceuticals Inc.
Country
United States (US)
ATC code
D11AX24
ATC class
Deoxycholic acid
Defined daily dose
1.79 mg, P
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 20, 2026

Packs & prices · 4

  • ndc11
    6116810103
    2 VIAL, GLASS in 1 CARTON (61168-101-03) / 2 mL in 1 VIAL, GLASS
  • ndc11
    6116810104
    4 VIAL, GLASS in 1 CARTON (61168-101-04) / 2 mL in 1 VIAL, GLASS (61168-101-01)
  • ndc11
    61168-101-03
  • ndc11
    61168-101-04

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

79 interactions on record for deoxycholic acid.

Graded by severity as the source publishes them — 79 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check deoxycholic acid against other medicinesHow interaction checks work

Deoxycholic acid · interactions on record

79 records

  • 79 moderate

Most severe, free to view

  • DicoumarolB01AA01moderate
  • WarfarinB01AA03moderate
  • HeparinB01AB01moderate
  • Antithrombin IIIB01AB02moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Deoxycholic acid in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All deoxycholic acid products

Authorised across Europe · EMA

The same active substance is authorised in 1 EEA country. Names it is sold under:

  • Portugal · Belkyra

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/879ce741-bf10-4bf5-8b4e-d0df7948b5c5
GET /v1/drugs/879ce741-bf10-4bf5-8b4e-d0df7948b5c5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "SUBCUTANEOUS",
  "source": "ndc",
  "strength": "20",
  "substance": "DEOXYCHOLIC ACID",
  "productndc": "61168-101",
  "dosage_form": "INJECTION, SOLUTION",
  "dea_schedule": null,
  "strength_unit": "mg/2mL",
  "application_number": "NDA206333",
  "marketing_category": "NDA"
}
API referenceMCP serverPlans

See everything about deoxycholic acid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console